| Original language | English |
|---|---|
| Pages (from-to) | 2372-2375 |
| Journal | Journal of rheumatology |
| Volume | 33 |
| Issue number | 12 |
| Publication status | Published - 2006 |
| Externally published | Yes |
Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials
Theodore Pincus, Yusuf Yazici, Ronald van Vollenhoven
Research output: Contribution to journal › Editorial › Academic › peer-review
16
Citations
(Scopus)